Red hair, MC1R variants, and risk for Parkinson's disease - a meta-analysis

被引:24
|
作者
Chen, Xiqun [1 ,2 ]
Feng, Danielle [1 ]
Schwarzschild, Michael A. [1 ]
Gao, Xiang [3 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Boston, MA 02129 USA
[2] Tongji Univ, Sch Med, Shanghai Hosp 10, Shanghai, Peoples R China
[3] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA
来源
基金
中国国家自然科学基金;
关键词
SKIN-CANCER; MELANOMA; NEUROMELANIN; EXPRESSION; RECEPTOR; SURFACE; CORE;
D O I
10.1002/acn3.381
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several studies have been conducted with mixed results since our initial report of increased Parkinson's disease risk in individuals with red hair and/or red hair-associated p.R151C variant of the MC1R gene, both of which confer high melanoma risk. We performed a meta-analysis of six publications on red hair, MC1R, and Parkinson's disease. We found that red hair (pooled odds ratios = 1.68, 95% confidence intervals: 1.07, 2.64) and p.R151C (pooled odds ratios = 1.10, 95% confidence intervals: 1.00, 1.21), but not p.R160W, were associated with greater risk for Parkinson's disease. Our results support potential roles of pigmentation and its key regulator MC1R in the pathogenesis of Parkinson's disease.
引用
收藏
页码:212 / 216
页数:5
相关论文
共 50 条
  • [31] Mitochondrial DNA variants, haplogroups and risk of Parkinson's disease: A systematic review and meta-analysis
    Sena-dos-Santos, Camille
    Moura, Dafne Dalledone
    Epifane-de-Assuncao, Matheus Caetano
    Ribeiro-dos-Santos, Andrea
    Santos-Lobato, Bruno Lopes
    PARKINSONISM & RELATED DISORDERS, 2024, 125
  • [32] MC1R germline variants confer risk for BRAF-mutant melanoma
    Landi, Maria Teresa
    Bauer, Juergen
    Pfeiffer, Ruth M.
    Elder, David E.
    Hulley, Benjamin
    Minghetti, Paola
    Calista, Donato
    Kanetsky, Peter A.
    Pinkel, Daniel
    Bastian, Boris C.
    SCIENCE, 2006, 313 (5786) : 521 - 522
  • [33] MC1R major variants are a risk factor of sleep lines in Caucasian women
    Jdid, R.
    Ezzedine, K.
    Latreille, J.
    Galan, P.
    Hercberg, S.
    Malvy, D.
    Tschachler, E.
    Guinot, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (06) : 805 - 809
  • [34] MC1R variants and melanoma risk: First study on Melan-Cohort
    Soufir, N.
    Miss, L. Bagait
    Miss, C. Oudin
    Wolkenstein, P.
    Descamps, V.
    Dupin, N.
    Lebbe, C.
    Basset-Seguin, N.
    Saiag, P.
    Grandchamp, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] MC1R minor variants and the multiple pathways to melanoma
    Duffy, David
    LANCET CHILD & ADOLESCENT HEALTH, 2019, 3 (05): : 287 - 288
  • [36] Germline MC1R variants and BRAF mutant melanoma
    Hacker, Elke
    Hayward, Nicholas K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (10) : 2354 - 2356
  • [37] Mutations of the P and MC1R genes produce OCA2 with red hair.
    Schmidt, RM
    Pietsch, JE
    Fryer, JP
    Summers, CG
    Oetting, WS
    King, RA
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 608 - 608
  • [38] Melanocortin 1 receptor (MC1R) gene variants and risk in cutaneous melanoma - A case-control analysis
    Niu, Jiangong
    Liu, Zhensheng
    Zhao, Hui
    Wang, Li-E
    Lee, Jeffrey
    Gershenwald, Jeffrey
    Grimm, Elizabeth
    Wei, Qingyi
    CANCER RESEARCH, 2009, 69
  • [39] Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
    Pranay Srivastava
    Shuhei Nishiyama
    Fang Zhou
    Sonia H. Lin
    Akriti Srivastava
    Chienwen Su
    Yuehang Xu
    Weiyi Peng
    Michael Levy
    Michael Schwarzschild
    Xiqun Chen
    Journal of Neuroimmune Pharmacology, 2023, 18 : 704 - 717
  • [40] Statin use and risk of Parkinson's disease: A meta-analysis
    Sheng, Zhiguo
    Jia, Xiaobo
    Kang, Meini
    BEHAVIOURAL BRAIN RESEARCH, 2016, 309 : 29 - 34